LONGEVITY VISION FUND
Longevity Vision Fund is a $100M investment fund dedicated to making longevity affordable and accessible to all. The fund accelerates longevity breakthroughs by investing in companies that develop technologies, products, and services that extend healthy human lifespans and overcome the negative effects of aging Longevity Vision Fund provides Seed to Series C funding to biotech and life extension-focused companies that have demonstrated affordable longevity potential and vision of milestones driving up the value of the company and market validation.
LONGEVITY VISION FUND
Social Links:
Industry:
Biotechnology Finance Life Science
Founded:
2018-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Google Maps Cloudflare JS CDN JS WordPress 6.0 Google Maps API UNPKG
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Signum Biosciences
Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-16 | Senda Biosciences | Longevity Vision Fund investment in Series C - Senda Biosciences | 123 M USD |
| 2022-04-19 | Tessera Therapeutics | Longevity Vision Fund investment in Series C - Tessera Therapeutics | 300 M USD |
| 2021-11-02 | Biolinq | Longevity Vision Fund investment in Series B - Biolinq | 100 M USD |
| 2021-08-30 | Laronde | Longevity Vision Fund investment in Series B - Laronde | 440 M USD |
| 2021-07-29 | Exo | Longevity Vision Fund investment in Series C - Exo | 220 M USD |
| 2021-06-10 | Senda Biosciences | Longevity Vision Fund investment in Series B - Senda Biosciences | 98 M USD |
| 2021-01-12 | Tessera Therapeutics | Longevity Vision Fund investment in Series B - Tessera Therapeutics | 230 M USD |
| 2021-01-11 | Valo Health | Longevity Vision Fund investment in Series B - Valo Health | 190 M USD |
| 2020-12-30 | LyGenesis | Longevity Vision Fund investment in Convertible Note - LyGenesis | 11 M USD |
| 2020-11-09 | Eko | Longevity Vision Fund investment in Series C - Eko | 65 M USD |
Newest Events participated